Currently, Checkpoint Therapeutics Inc [CKPT] is trading at $3.33, saw in change for the day. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CKPT shares have gain 3.74% over the last week, with a monthly amount drifted -9.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Checkpoint Therapeutics Inc [NASDAQ: CKPT] stock has seen the most recent analyst activity on January 13, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $9. On June 09, 2021, B. Riley Securities initiated with a Buy rating and assigned a price target of $18 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $16 on January 20, 2021. Lake Street initiated its recommendation with a Buy. H.C. Wainwright started tracking with a Buy rating for this stock on December 08, 2017, and assigned it a price target of $11.
This stock has fluctuated between a low of $1.38 and a high of $4.50 over the last 52 weeks. Checkpoint Therapeutics Inc [NASDAQ: CKPT] shares were valued at $3.33 at the most recent close of the market.
Analyzing the CKPT fundamentals
Trailing Twelve Months sales for Checkpoint Therapeutics Inc [NASDAQ:CKPT] were 0.05M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at -451.68% with Operating Profit Margin at -798.17%, Pretax Profit Margin comes in at -988.68%, and Net Profit Margin reading is -988.68%. To continue investigating profitability, this company’s Return on Assets is posted at -8.97, Equity is 3.6 and Total Capital is 2.98.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.25 points at the first support level, and at 3.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.41, and for the 2nd resistance point, it is at 3.50.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Checkpoint Therapeutics Inc [NASDAQ:CKPT] is 0.29. Also, the Quick Ratio is 0.29, while the Cash Ratio stands at 0.26. Considering the valuation of this stock, the price to sales ratio is 3252.20.
Transactions by insiders
Recent insider trading involved Oliviero James F III, CEO, President and Director, that happened on Dec 18 ’24 when 0.6 million shares were sold. CEO, President and Director, Oliviero James F III completed a deal on Dec 19 ’24 to sell 0.22 million shares. Meanwhile, Chief Financial Officer GRAY WILLIAM GARRETT sold 0.27 million shares on Dec 18 ’24.
